Regeneron halts antibody trial in seriously ill Covid patients

Drug hailed as coronavirus ‘cure’ by Donald Trump will still be studied in mild-to-moderate cases
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news